Inflammatory Choroidal Neovascularization

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-08-08
Clinical Trial Update: Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA). [Phase 2]
Phase 2 trial evaluating aflibercept for inflammatory choroidal neovascularization in young patients has completed.